The Expected Impact of Oncology Biosimilars In Brazil And Mexico- Payers and Oncologists Consider The cost-Effectiveness of These Cheaper Alternatives
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1237
https://www.valueinhealthjournal.com/article/S1098-3015(15)01294-2/fulltext
Title :
The Expected Impact of Oncology Biosimilars In Brazil And Mexico- Payers and Oncologists Consider The cost-Effectiveness of These Cheaper Alternatives
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01294-2&doi=10.1016/j.jval.2015.03.1237
First page :
A213
Section Title :
Cancer
Open access? :
No
Section Order :
701